Publicaciones en colaboración con investigadores/as de Hospital Universitari de Bellvitge (7)

2019

  1. Metformin induces a fasting- and antifolate-mimicking modification of systemic host metabolism in breast cancer patients

    Aging, Vol. 11, Núm. 9, pp. 2874-2888

  2. Neoadjuvant metformin added to systemic therapy decreases the proliferative capacity of residual breast cancer

    Journal of Clinical Medicine, Vol. 8, Núm. 12

  3. Oncogenesis of the endometrial polyp. Clinical management through biomolecular markers

    Progresos de Obstetricia y Ginecologia, Vol. 62, Núm. 6, pp. 559-566

  4. The C allele of ATM rs11212617 associates with higher pathological complete remission rate in breast cancer patients treated with neoadjuvant metformin

    Frontiers in Oncology, Vol. 9, Núm. MAR

2018

  1. A phase 2 trial of neoadjuvant metformin in combination with trastuzumab and chemotherapy in women with early HER2-positive breast cancer: The METTEN study

    Oncotarget, Vol. 9, Núm. 86, pp. 35687-35704

2014

  1. Nomogram including the total tumoral load in the sentinel nodes assessed by one-step nucleic acid amplification as a new factor for predicting nonsentinel lymph node metastasis in breast cancer patients

    Breast Cancer Research and Treatment, Vol. 147, Núm. 2, pp. 371-380

2012

  1. Continuation rate of combined hormonal contraception: A prospective multicenter study

    Journal of Women's Health, Vol. 21, Núm. 5, pp. 490-495